FDA Advisory Panel Votes to Recommend Non-Adjunctive Use of Dexcom G5 Mobile CGM

Diabetes Technol Ther. 2016 Aug;18(8):512-6. doi: 10.1089/dia.2016.07252.mr. Epub 2016 Jul 29.

MeSH terms

  • Advisory Committees*
  • Blood Glucose / analysis*
  • Blood Glucose Self-Monitoring
  • Calibration
  • Device Approval
  • Diabetes Mellitus, Type 1 / blood*
  • Diabetes Mellitus, Type 1 / drug therapy
  • Drug Monitoring
  • Humans
  • Hyperglycemia / diagnosis*
  • Hyperglycemia / prevention & control
  • Hypoglycemia / chemically induced
  • Hypoglycemia / diagnosis*
  • Hypoglycemia / prevention & control
  • Hypoglycemic Agents / administration & dosage
  • Hypoglycemic Agents / adverse effects
  • Hypoglycemic Agents / therapeutic use
  • Insulin / administration & dosage
  • Insulin / adverse effects
  • Insulin / therapeutic use
  • Monitoring, Ambulatory / adverse effects
  • Monitoring, Ambulatory / instrumentation*
  • Patient Education as Topic
  • Practice Guidelines as Topic
  • Quality of Life
  • United States
  • United States Food and Drug Administration*

Substances

  • Blood Glucose
  • Hypoglycemic Agents
  • Insulin